May 13, 2020
Richmond pharmaceutical company expands into Canada
Richmond-based pharmaceutical company Kaléo announced Wednesday it is expanding its market to Canada, offering its epinephrine auto-injector Allerject. The product used to treat severe allergic reactions will be available in pharmacies across Canada starting May 19. In response to a shortage of EpiPen in Canada in 2018, Kaléo’s original epinephrine auto-injector Auvi-Q was available in [[...]